The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Griffin Michelle Renee since 2020.
This trader's CIK number is 1229765.
At the time of last reporting, Griffin Michelle Renee was the Director of Adaptive Biotechnologies Corp. (stock ticker symbol ADPT).
Also see all insider trading activities at Adaptive Biotechnologies Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | KDNY | 0 | $0 | 0 | $0 | 3,300 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ADPT | 0 | $0 | 36,291 | $260,932 | 0 | $0 |
| 2023 | ADPT | 0 | $0 | 2,341 | $19,877 | 0 | $0 |
| 2021 | ADPT | 0 | $0 | 48,916 | $2,197,768 | 48,916 | $381,544 |
| 2020 | ADPT | 0 | $0 | 24,000 | $1,272,552 | 24,000 | $187,200 |
1. Chinook Therapeutics, Inc. (KDNY)
2. Adaptive Biotechnologies Corp (ADPT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-05-26 | KDNY | Option Ex | 3,300 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-13 | ADPT | Sale | 36,291 | 7.19 | 260,932 |
| 2023-03-27 | ADPT | Sale | 2,341 | 8.49 | 19,877 |
| 2021-08-27 | ADPT | Option Ex | 14,916 | 7.80 | 116,344 |
| 2021-08-27 | ADPT | Sale | 14,916 | 35.00 | 522,060 |
| 2021-07-14 | ADPT | Option Ex | 2,500 | 7.80 | 19,500 |
| 2021-07-14 | ADPT | Sale | 2,500 | 36.80 | 92,000 |
| 2021-06-17 | ADPT | Sale | 4,000 | 40.00 | 160,000 |
| 2021-06-17 | ADPT | Option Ex | 4,000 | 7.80 | 31,200 |
| 2021-06-14 | ADPT | Sale | 2,500 | 38.56 | 96,400 |
| 2021-06-14 | ADPT | Option Ex | 2,500 | 7.80 | 19,500 |
| 2021-05-18 | ADPT | Sale | 2,500 | 35.00 | 87,500 |
| 2021-05-18 | ADPT | Option Ex | 2,500 | 7.80 | 19,500 |
| 2021-04-14 | ADPT | Option Ex | 4,500 | 7.80 | 35,100 |
| 2021-04-14 | ADPT | Sale | 4,500 | 43.41 | 195,344 |
| 2021-03-15 | ADPT | Option Ex | 4,500 | 7.80 | 35,100 |
| 2021-03-16 | ADPT | Option Ex | 1,500 | 7.80 | 11,700 |
| 2021-03-15 | ADPT | Sale | 4,500 | 41.53 | 186,885 |
| 2021-03-16 | ADPT | Sale | 1,500 | 47.00 | 70,500 |
| 2021-02-16 | ADPT | Sale | 6,000 | 65.08 | 390,480 |
| 2021-02-16 | ADPT | Option Ex | 6,000 | 7.80 | 46,800 |
| 2021-01-14 | ADPT | Sale | 6,000 | 66.10 | 396,599 |
| 2021-01-14 | ADPT | Option Ex | 6,000 | 7.80 | 46,800 |
| 2020-12-14 | ADPT | Option Ex | 6,000 | 7.80 | 46,800 |
| 2020-12-14 | ADPT | Sale | 6,000 | 58.61 | 351,642 |
| 2020-11-16 | ADPT | Option Ex | 6,000 | 7.80 | 46,800 |
| 2020-11-16 | ADPT | Sale | 6,000 | 47.94 | 287,610 |
| 2020-10-14 | ADPT | Option Ex | 12,000 | 7.80 | 93,600 |
| 2020-10-14 | ADPT | Sale | 12,000 | 52.77 | 633,300 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Griffin Michelle Renee (Director of Adaptive Biotechnologies Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.